Ontology highlight
ABSTRACT: Importance
More than 50% of older adults with late-life major depressive disorder fail to respond to initial treatment with first-line pharmacological therapy.Objectives
To assess typical patterns of response to an open-label trial of extended-release venlafaxine hydrochloride (venlafaxine XR) for late-life depression and to evaluate which clinical factors are associated with the identified longitudinal response patterns.Design, setting, and participants
Group-based trajectory modeling was applied to data from a 12-week open-label pharmacological trial conducted in specialty care as part of the Incomplete Response in Late Life: Getting to Remission Study. Clinical prognostic factors, including domain-specific cognitive performance and individual depression symptoms,
SUBMITTER: Smagula SF
PROVIDER: S-EPMC4718144 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature